North of Los Angeles is a section of the California desert where hangars are low and unmarked, and the air is heavy with the dry stench of aviation fuel and creosote. Palmdale doesn’t promote its products. It has never done so. However, anyone familiar with defense aerospace is aware that something noteworthy is currently taking place behind the fences at Plant 42, and the figures beginning to surface from Northrop Grumman’s earnings calls are beginning to support this.
CEO Kathy Warden announced in late April that the company would invest $2.5 billion of its own funds in accelerating B-21 Raider production during a financial call that most people outside the defense beat probably missed. This year, 200 million of those land. The remainder is used during the critical period between 2027 and 2029, when a 25% increase in production pace is anticipated. That’s not a hedge for a company that has already invested over $5 billion in the program’s manufacturing and digital foundation. It’s a pledge.
Context is important. Northrop is contributing $4.5 billion of its own through reconciliation funding, and the Air Force and Northrop completed their accelerated-production agreement back in February. There is open discussion about increasing the fleet size from 100 to about 145 aircraft, which would be a significant shift in scope for a program that was almost entirely secret until recently. As this develops, it’s difficult to ignore how the B-21 has changed from being a highly classified replacement for the B-2 to something the Pentagon wants Beijing and the general public to know is arriving more quickly.
Currently, Palmdale produces seven to eight aircraft annually; a 25% increase would result in about two more bombers. That may seem insignificant, but keep in mind that each one costs roughly $700 million, and strategic bombers have historically been produced at a rate measured in handfuls every ten years. After all, there were only 21 B-2s in the fleet. Just within its low-rate initial production lots, the B-21 is scheduled to begin production at 21, and that is just the start of the run.
Whether the economics genuinely improve at scale is the question that looms over all of this. When describing the new agreement as one that “improves the economics for the program for the government and Northrop Grumman,” Warden was cautious, almost legalistic. This is the kind of phrase that simultaneously conveys everything and nothing. Unit-cost reductions promised by defense programs have a long history of disappearing into the supply chain. Vendors of engines fail. Integrators of avionics lag behind. It would be reasonable to remain skeptical until the numbers settle, as there is currently no public indication that the new agreement has significantly lowered the per-aircraft price below $700 million.
However, this program does feel different in some way. In September 2025, Edwards Air Force Base received the second flight prototype, which doubled test capacity over night. Midway through April, a KC-135 was used for aerial refueling trials. Since most stealth programs surprise people in the opposite direction, the Combined Test Force has been discreetly reporting that real-world performance is outperforming the digital twin’s predictions. This is a small but telling detail. Investors appear to think the program has finally reached the end of its dangerous phase.
Speaking with those who follow defense industries gives me the impression that the B-21 is now more than just a bomber contract. As China continues to test its own next-generation airframes, it serves as a gauge for the United States’ ability to continue producing sophisticated strategic hardware on a reasonable timeline. The bomber’s name was given by the Doolittle Raiders, a somewhat archaic gesture in a time of open-architecture software and digital twins. In the end, what those Palmdale hangars actually produce in 2027 will determine whether the program lives up to the comparison.
